Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced
Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the response rate obtained in an heterogeneous
oncologic population treated by chemotherapy, and either by Darbepoetin alfa classic
treatment or by association of Darbepoetin alfa -ferric saccharose systematic
supplementation, administered concomitantly with chemotherapy.